Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia

American Journal of Medical Genetics

Volumn 130 A, Issue 1, 2004, Pages 73-75

  Van Der Vleuten, Gerly M ^a   Hijmans, Anneke ^a   Kluijtmans, Leo A J ^a   Blom, Henk J ^a   Stalenhoef, Anton F H ^a   De Graaf, Jacqueline ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

FCH; TXNIP gene

Indexed keywords

BINDING PROTEIN; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; CHROMOSOME 1Q; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FAMILIAL COMBINED HYPERLIPIDEMIA; FEMALE; GENE; GENE LOCUS; HUMAN; HYPERLIPIDEMIA; MALE; NETHERLANDS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TXNIP GENE;

EID: 4344563211     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30036     Document Type: Conference Paper

References (20)

1. Assmann G, Schulte H. 1992. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70:733-737.
2. Bodnar JS, Chatterjee A, Castellani LW, Ross DA, Ohmen J, Cavalcoli J, Wu C, Dains KM, Catanese J, Chu M, Sheth SS, Charugundla K, Demant P, West DB, de Jong P, Lusis AJ. 2002. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat Genet 30:110-116.
3. Bredie SJ, Kiemeney LA, de Haan AF, Demacker PN, Stalenhoef AF. 1996. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet 58:812-822.
4. Bredie SJ, Demacker PN, Stalenhoef AF. 1997. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity. Eur J Clin Invest 27:802-811.
5. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL. 1976. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 25:313-320.
6. Castellani LW, Weinreb A, Bodnar J, Goto AM, Doolittle M, Mehrabian M, Demant P, Lusis AJ. 1998. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat Genet 18:374-377.
7. Castro CM, de Bruin TW, de Valk HW, Shoulders CC, Jansen H, Willem ED. 1993. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 92:160-168.
8. Chen KS, DeLuca HF. 1994. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1219:26-32.
9. Coon H, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L, Leppert MF. 2000. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 20:2275-2280.
10. de Graaf J, Stalenhoef AF. 1998. Defects of lipoprotein metabolism in familial combined hyperlipidaemia. Curr Opin Lipidol 9:189-196.
11. de Graaf J, Swinkels DW, de Haan AF, Demacker PN, Stalenhoef AF. 1992. Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families. Am J Hum Genet 51:1295-1310.
12. de Graaf J, Veerkamp MJ, Stalenhoef AF. 2002. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism, and free fatty acids. J R Soc Med 95(Suppl 42):46-53.
13. Demacker PN, Veerkamp MJ, Bredie SJ, Marcovina SM, de Graaf J, Stalenhoef AF. 2000. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: A study in familial combined hyperlipidemia. Atherosclerosis 153:483-490.
14. Juo SH, Bredie SJ, Kiemeney LA, Demacker PN, Stalenhoef AF. 1998. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia. Am J Hum Genet 63:586-594.
15. Ludwig DL, Kotanides H, Le T, Chavkin D, Bohlen P, Witte L. 2001. Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene. Gene 269:103-112.
16. Nishiyama A, Masutani H, Nakamura H, Nishinaka Y, Yodoi J. 2001. Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 52:29-33.
17. Pajukanta P, Bodnar JS, Sallinen R, Chu M, Airaksinen T, Qunong X, Castellani LW, Sheth SS, Wessman M, Palotie A, Sinsheimer JS, Demant P, Lusis AJ, Peltonen L. 2001. Fine mapping of Hyplip 1 and the human homolog, a potential locus for FCHL. Mamm Genome 12(3):238-245.
18. Pei W, Baron H, Muller-Myhsok B, Knoblauch H, Al Yahyaee SA, Hui R, Wu X, Liu L, Busjahn A, Luft FC, Schuster H. 2000. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families. Clin Genet 57:29-34.
19. Swinkels DW, Hak-Lemmers HL, Demacker PN. 1987. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res 28:1233-1239.
20. Veerkamp MJ, de Graaf J, Bredie SJ, Hendriks JC, Demacker PN, Stalenhoef AF. 2002. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: Results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol 22:274-282.